Steven Schutzer from Rutgers New Jersey Medical School is leading a team assessing new vaccine strategies for Lyme disease, including a hybrid approach that can deliver a one-two punch to the microbe that causes the disease and its tick carrier. Learn more.
Recent Posts
- Rutgers-Newark Searches for New Ways to Enroll Men in Alzheimer’s Studies.
- Clinical Trials Day 2026 is May 20th – Submit an Abstract by February 13th
- Clinical trial in N.J. gives patients with incurable cancer a new chance at life.
- Entrepreneurship Lessons Coming to Introductory Engineering Courses.
- Scientists Develop Plastics That Can Break Down, Tackling Pollution.
Categories
- Community (2,431)
- Covid (996)
- CTO Events (6)
- News (3,078)
- Pilots (21)